Elevance Health Inc
SWB:A58
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Elevance Health Inc
SWB:A58
|
US |
|
REA Group Ltd
ASX:REA
|
AU |
|
P
|
Primoris Services Corp
NYSE:PRIM
|
US |
|
R
|
Reach PLC
F:MRR
|
UK |
|
Quest Diagnostics Inc
NYSE:DGX
|
US |
|
S
|
Speciality Restaurants Ltd
NSE:SPECIALITY
|
IN |
|
I
|
Intel Corp
XHAM:INL
|
US |
|
F
|
Franklin Resources Inc
LSE:0RT6
|
US |
|
United Parcel Service Inc
NYSE:UPS
|
US |
|
S
|
Santhera Pharmaceuticals Holding AG
OTC:SPHDF
|
CH |
|
A
|
Alcoa Corp
F:185
|
US |
|
Toyo Tire Corp
OTC:TOTTF
|
JP |
Wall St Price Targets
A58 Price Targets Summary
Elevance Health Inc
According to Wall Street analysts, the average 1-year price target for A58 is 370.78 EUR with a low forecast of 291.9 EUR and a high forecast of 456.56 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is A58's stock price target?
Price Target
370.78
EUR
According to Wall Street analysts, the average 1-year price target for A58 is 370.78 EUR with a low forecast of 291.9 EUR and a high forecast of 456.56 EUR.
What is the Revenue forecast for Elevance Health Inc?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 2%.
What is the Net Income forecast for Elevance Health Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 3 years is 8%.
